News and innovation April 29, 2024
EU Directive 2022/431: What’s in it for healthcare workers?
EU Directive 2022/431 in a nutshell European Union (EU) Directive 2022/431, also known as the Carcinogens, Mutagens and Reprotoxic Substances…
EU Directive 2022/431: What’s in it for healthcare workers?
EU Directive 2022/431 in a nutshell European Union (EU) Directive 2022/431, also known as the Carcinogens, Mutagens and Reprotoxic Substances…
BD IV News 2.0: building an IV therapy community
Your source of information on IV therapy just got a whole lot better. Following feedback from readers, BD IV News…
“Complications of IV catheter therapy are simply the result of one complex and highly variable mechanical system—IV catheter equipment design,...
Best practices for phase 1 investigational drugs trials
Before pharmaceutical products are released onto the market, they undergo extensive screening as an investigational drug (IND, or investigational new…
Key insights on recent amendments to EU-MDR
The European Medical Device Regulation (EU-MDR) 2017/745 has brought many changes to the medical device industry and product availability. Thanks…
Quality control of prefilled flush syringes: key considerations
Before delving into the quality control of prefilled flush syringes, which are an integral part of vascular access management (VAM),…
Antibiotics shortages in Europe: what you need to know
“A new approach is needed to better tackle medicines shortages in the European Health Union,” the European Commission said in…